ClinVar Miner

Submissions for variant NM_000268.4(NF2):c.922A>G (p.Met308Val)

dbSNP: rs2066686693
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001346791 SCV001541017 uncertain significance Neurofibromatosis, type 2 2020-07-23 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with NF2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces methionine with valine at codon 308 of the NF2 protein (p.Met308Val). The methionine residue is highly conserved and there is a small physicochemical difference between methionine and valine.
Ambry Genetics RCV002377471 SCV002686791 uncertain significance Hereditary cancer-predisposing syndrome 2021-05-28 criteria provided, single submitter clinical testing The p.M308V variant (also known as c.922A>G), located in coding exon 10 of the NF2 gene, results from an A to G substitution at nucleotide position 922. The methionine at codon 308 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.